Cipla’s Manufacturing Units In India Under U.S. FDA Lens; Inspectional Observations Issued

MUMBAI - U.S. FDA conducted inspections of three manufacturing sites belonging to Indian drug maker Cipla and issued nine to 10 "Inspectional Observations" on various manufacturing issues. The manufacturing sites inspected by FDA are in Goa, Kurkumbh and Bangalore